C6-NBD GALACTOSYL CERAMIDE

Code: 810220p-250ug D2-231

Application

C6-NBD Galactosyl Ceramide is suitable for use as a substrate in neutral β-glycosylceramidase (GCase) activity assay.

Biochem/physiol Actions

read more

Your Price
£1,280.00 250UG
£1,536.00 inc. VAT

Application

C6-NBD Galactosyl Ceramide is suitable for use as a substrate in neutral β-glycosylceramidase (GCase) activity assay.

Biochem/physiol Actions

Galactosyl ceramide is also known as galactocerebroside and is produced in the lumen of the endoplasmic reticulum. Galactosyl ceramide is a vaccine adjuvant, it stimulates natural killer T (NKT) cells to increase secretion of T helper type 1 (Th1) and T-helper type 2 (TH2) cytokines. Galactosyl ceramide accumulation in excess is responsible for diseases such as Krabbe′s disease. Galactocerebroside is a precursor of3′-sulfo-galactosylceramide, a vital sulfoglycolipid found in the brain and other organs.

General description

C6-NBD Galactosyl Ceramide is a fluorescent analog of the sphingolipid, galactosyl ceramide. Its fluorescent property is due to presence of NBD (2-(4-nitro-2,1,3-benzoxadiazol-7-yl) aminoethyl) group.

Packaging

5 mL Amber Glass Screw Cap Vial (810220P-250ug)

assay>99% (TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids 810220P
packagingpkg of 1 × 250 µg (810220P-250ug)
shipped indry ice
storage temp.−20°C
Cas Number170212-26-7
This product has met the following criteria: